Effects on resting cerebral blood flow and functional connectivity induced by metoclopramide: A perfusion MRI study in healthy volunteers

British Journal of Pharmacology

Volumn 163, Issue 8, 2011, Pages 1639-1652

  Fernández Seara, María A ^a   Aznárez Sanado, Maite ^a   Mengual, Elisa ^a,b   Irigoyen, Jaione ^a   Heukamp, Franz ^c   Pastor, María A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c IESE BUSINESS SCHOOL   (Spain)

Author keywords

antipsychotic; arterial spin labelling; basal ganglia metabolism; cerebral perfusion; functional connectivity; insula; metoclopramide

Indexed keywords

DOPAMINE 2 RECEPTOR; METOCLOPRAMIDE; PLACEBO;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN PERFUSION; DIASTOLIC BLOOD PRESSURE; DIZZINESS; FEMALE; GLOBUS PALLIDUS; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INSULA; INTERNAL CAROTID ARTERY; MALE; MENTAL DISEASE; MIDDLE TEMPORAL GYRUS; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL OPERCULUM; PERFUSION WEIGHTED IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; SINGLE DRUG DOSE; SPIN LABELING; SUPERIOR TEMPORAL GYRUS; SYSTOLIC BLOOD PRESSURE; TEMPORAL LOBE; THALAMUS; VERTEBRAL ARTERY;

ADMINISTRATION, ORAL; ADULT; ARTERIES; BRAIN; CEREBROVASCULAR CIRCULATION; CONTROL GROUPS; DOPAMINE ANTAGONISTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METOCLOPRAMIDE; PLACEBOS; REPRODUCIBILITY OF RESULTS; REST; SINGLE-BLIND METHOD; SPIN LABELS; YOUNG ADULT;

EID: 79955020949     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01161.x     Document Type: Article

References (72)

1. Agid O, Seeman P, Kapur S, (2006). The 'delayed onset' of antipsychotic action-an idea whose time has come and gone. J Psychiatry Neurosci 31: 93-100.
2. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 158 (Suppl. 1): S1-S254.
3. de Almeida J, Mengod G, (2010). D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment. Neuroscience 170: 1133-1139.
4. Anfinson TJ, (2002). Akathisia, panic, agoraphobia, and major depression following brief exposure to metoclopramide. Psychopharmacol Bull 36: 82-93.
5. Aslan S, Xu F, Wang PL, Uh J, Yezhuvath US, van Osch M, et al,. (2010). Estimation of labeling efficiency in pseudocontinuous arterial spin labeling. Magn Reson Med 63: 765-771.
6. Augustine JR, (1996). Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev 22: 229-244. (Pubitemid 26390178)
7. Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, et al,. (1994). Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psychiatry 151: 681-686. (Pubitemid 24140556)
8. Blanco M, Jelambi I, Perez G, Gomez J, Franco T, Hurtado N, et al,. (1996). The effect of intravenous metoclopramide on blood pressure in normotensive and hypertensive subjects. Int J Clin Pharmacol Ther 34: 390-392. (Pubitemid 26305812)
9. Brusa L, Bassi A, Pierantozzi M, Gaudiello SFF, Floris R, Stanzione P, (2002). Perfusion-weighted dynamic susceptibility (DSC) MRI: basal ganglia hemodynamic changes after apomorphine in Parkinson's disease. Neurol Sci 23 (Suppl. 2): S61-S62. (Pubitemid 35355777)
10. Buxton RB, Frank LR, (1997). A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation. J Cereb Blood Flow Metab 17: 64-72. (Pubitemid 27014909)
11. Cebral JR, Castro MA, Putman CM, Alperin N, (2008). Flow-area relationship in internal carotid and vertebral arteries. Physiol Meas 29: 585-594. (Pubitemid 351875524)
12. Chuang KH, van Gelderen P, Merkle H, Bodurka J, Ikonomidou VN, Koretsky AP, et al,. (2008). Mapping resting-state functional connectivity using perfusion MRI. Neuroimage 40: 1595-1605.
13. Craig AD, (2009). How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci 10: 59-70.
14. Dai W, Garcia D, de Bazelaire C, Alsop DC, (2008). Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 60: 1488-1497.
15. Detre JA, Leigh JS, Williams DS, Koretsky AP, (1992). Perfusion imaging. Magn Reson Med 23: 37-45.
16. Detre JA, Wang J, Wang Z, Rao H, (2009). Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Curr Opin Neurol 22: 348-355.
17. Eckert T, Tang C, Eidelberg D, (2007). Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 6: 926-932. (Pubitemid 47405003)
18. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, et al,. (2005). A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25: 1325-1335. (Pubitemid 40591672)
19. Farde L, Hall H, Ehrin E, Sedvall G, (1986). Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231: 258-261. (Pubitemid 16160075)
20. Fass R, Pieniaszek HJ, Thompson JR, (2009). Pharmacokinetic comparison of orally-disintegrating metoclopramide with conventional metoclopramide tablet formulation in healthy volunteers. Aliment Pharmacol Ther 30: 301-306.
21. Feltes TF, Hansen TN, Martin CG, Leblanc AL, Smith S, Giesler ME, (1987). The effects of dopamine infusion on regional blood flow in newborn lambs. Pediatr Res 21: 131-136. (Pubitemid 17015213)
22. Floyd TF, Ratcliffe SJ, Wang J, Resch B, Detre JA, (2003). Precision of the CASL-perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories. J Magn Reson Imaging 18: 649-655. (Pubitemid 37467265)
23. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME, (2005). The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 102: 9673-9678. (Pubitemid 40981739)
24. Gaspar P, Bloch B, Le Moine C, (1995). D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci 7: 1050-1063.
25. Genovese CR, Lazar NA, Nichols T, (2002). Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15: 870-878. (Pubitemid 34852500)
26. Gevers S, van Osch MJ, Hendrikse J, Bokkers RP, Kies DA, Teeuwisse WM, et al,. (2009). Multicenter reproducibility of continuous, pulsed and pseudo-continuous arterial spin labeling; can we use general reference values of cerebral blood flow? In Proc Intl Soc Mag Reson Med 17: 626. Honolulu.
27. Gibb WR, Lees AJ, (1991). Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54: 388-396.
28. Goldman-Rakic PS, Lidow MS, Smiley JF, Williams MS, (1992). The anatomy of dopamine in monkey and human prefrontal cortex. J Neural Transm Suppl 36: 163-177.
29. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE, (2004). Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 22: 676-687. (Pubitemid 38759430)
30. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA, (1996). Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry 153: 41-49. (Pubitemid 26026156)
31. Hoyer D, (1990). Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors. Neuropsychopharmacology 3: 371-383.
32. Hsu JL, Jung TP, Hsu CY, Hsu WC, Chen YK, Duann JR, et al,. (2007). Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction. Eur J Nucl Med Mol Imaging 34: 1458-1466.
33. Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, et al,. (2001). Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 193: 29-36. (Pubitemid 33062392)
34. Kita H, Chiken S, Tachibana Y, Nambu A, (2006). Origins of GABA(A) and GABA(B) receptor-mediated responses of globus pallidus induced after stimulation of the putamen in the monkey. J Neurosci 26: 6554-6562. (Pubitemid 44318336)
35. Kluge M, Schussler P, Steiger A, (2007). Persistent generalized anxiety after brief exposure to the dopamine antagonist metoclopramide. Psychiatry Clin Neurosci 61: 193-195. (Pubitemid 46365267)
36. Kofke WA, Blissitt PA, Rao H, Wang J, Addya K, Detre J, (2007). Remifentanil-induced cerebral blood flow effects in normal humans: dose and ApoE genotype. Anesth Analg 105: 167-175. (Pubitemid 46975863)
37. Kozlowski MR, Marshall JF, (1980). Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement. Brain Res 197: 167-183. (Pubitemid 10036871)
38. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA, (2003). Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry 53: 601-608. (Pubitemid 36385062)
39. Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH, (2005). Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Res 139: 19-30. (Pubitemid 40800434)
40. Lehericy S, Benali H, Van de Moortele PF, Pelegrini-Issac M, Waechter T, Ugurbil K, et al,. (2005). Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. Proc Natl Acad Sci U S A 102: 12566-12571. (Pubitemid 41266399)
41. Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P, (1991). Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience 40: 657-671.
42. Liu X, Van Natta K, Yeo H, Vilenski O, Weller PE, Worboys PD, et al,. (2009). Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab Dispos 37: 787-793.
43. Ma Y, Huang C, Dyke JP, Pan H, Alsop D, Feigin A, et al,. (2010). Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab 30: 505-509.
44. MacDonald TM, (1991). Metoclopramide, domperidone and dopamine in man: actions and interactions. Eur J Clin Pharmacol 40: 225-230.
45. MacIntosh BJ, Pattinson KT, Gallichan D, Ahmad I, Miller KL, Feinberg DA, et al,. (2008). Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling. J Cereb Blood Flow Metab 28: 1514-1522.
46. Martres MP, Sales N, Bouthenet ML, Schwartz JC, (1985). Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride. Eur J Pharmacol 118: 211-219. (Pubitemid 16179845)
47. Mercuri N, Bernardi G, Calabresi P, Cotugno A, Levi G, Stanzione P, (1985). Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms. Brain Res 358: 110-121. (Pubitemid 16184080)
48. Miller LG, Jankovic J, (1989). Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 149: 2486-2492. (Pubitemid 19283205)
49. Nagai M, Kishi K, Kato S, (2007). Insular cortex and neuropsychiatric disorders: a review of recent literature. Eur Psychiatry 22: 387-394. (Pubitemid 47391217)
50. O'Gorman RL, Mehta MA, Asherson P, Zelaya FO, Brookes KJ, Toone BK, et al,. (2008). Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: a non-invasive MRI pilot study. Neuroimage 42: 36-41.
51. Palombo E, Porrino LJ, Bankiewicz KS, Crane AM, Sokoloff L, Kopin IJ, (1990). Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP. J Neurosci 10: 860-869. (Pubitemid 20104784)
52. Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J, (2006). Drug Insight: from disturbed motility to disordered movement-a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol 3: 138-148.
53. Pratt JA, Winchester C, Egerton A, Cochran SM, Morris BJ, (2008). Modelling prefrontal cortex deficits in schizophrenia: implications for treatment. Br J Pharmacol 153 (Suppl. 1): S465-S470. (Pubitemid 351341020)
54. Raichle ME, (1998). Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci U S A 95: 765-772. (Pubitemid 28124866)
55. Rogers BP, Morgan VL, Newton AT, Gore JC, (2007). Assessing functional connectivity in the human brain by fMRI. Magn Reson Imaging 25: 1347-1357. (Pubitemid 350122908)
56. Rzezniczak HW, Gundlach AL, Beart PM, (1982). Labelling of high (D-2 receptor) and low affinity sites by [3H]domperidone in homogenates of the corpus striatum of the rat. Neurosci Lett 30: 63-68. (Pubitemid 12008925)
57. Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, et al,. (2007). Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 27: 2349-2356. (Pubitemid 46340968)
58. Seeman P, (2010). All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2 receptors. CNS Neurosci Ther [Epub ahead of print].
59. Shearer RM, Bownes IT, Curran P, (1984). Tardive akathisia and agitated depression during metoclopramide therapy. Acta Psychiatr Scand 70: 428-431. (Pubitemid 15182216)
60. Stanley M, Lautin A, Rotrosen J, Gershon S, Kleinberg D, (1980). Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models. Psychopharmacology (Berl) 71: 219-225. (Pubitemid 11193997)
61. Wang J, Alsop DC, Li L, Listerud J, Gonzalez-At JB, Schnall MD, et al,. (2002). Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 48: 242-254. (Pubitemid 34809412)
62. Wang J, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA, (2005). Amplitude modulated continuous arterial spin labeling perfusion MR with single coil at 3.0 Tesla. Radiology 235: 218-228.
63. Weddington WW, Jr, Banner A, (1986). Organic affective syndrome associated with metoclopramide: case report. J Clin Psychiatry 47: 208-209. (Pubitemid 16109761)
64. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB, (2003). Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol 16: 178-183. (Pubitemid 37409029)
65. Wik G, Wiesel FA, Sjogren I, Blomqvist G, Greitz T, Stone-Elander S, (1989). Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography. Psychopharmacology (Berl) 97: 309-318. (Pubitemid 19103421)
66. Williams DS, Detre JA, Leigh JS, Koretsky AP, (1992). Magnetic resonance imaging of perfusion using spin inversion of arterial water. [erratum appears in Proc Natl Acad Sci U S A 1992 May 1;89(9):4220]. Proc Natl Acad Sci U S A 89: 212-216.
67. Wong EC, (2007). Vessel-encoded arterial spin-labeling using pseudocontinuous tagging. Magn Reson Med 58: 1086-1091. (Pubitemid 350234194)
68. Wong EC, Buxton RB, Frank LR, (1998). Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II). Magn Reson Med 39: 702-708. (Pubitemid 28189141)
69. Wu WC, Fernandez-Seara M, Detre JA, Wehrli FW, Wang J, (2007). A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 58: 1020-1027. (Pubitemid 350074370)
70. Ye FQ, Berman KF, Ellmore T, Esposito G, van Horn JD, Yang Y, et al,. (2000). H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med 44: 450-456.
71. Yoshikawa T, Yoshida N, Mine Y, Hosoki K, (1998). Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum. Jpn J Pharmacol 77: 53-59. (Pubitemid 28263990)
72. Zgaljardic DJ, Borod JC, Foldi NS, Mattis PJ, Gordon MF, Feigin A, et al,. (2006). An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol 28: 1127-1144. (Pubitemid 44091931)